No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
ZHONG JI LS: Annual Report 2024
Announcement highlights | March New energy Fund performance report released: Leapmotor tops the delivery chart for the first time, Xiaopeng grows by 268% year-on-year; UBTECH executives collectively Buy company Stocks, and further Shareholding at the righ
BYD Company: March sales were 0.37742 million vehicles, a year-on-year increase of 24.78%; NIO delivered 0.015 million Autos in March, a year-on-year increase of 26.7%; Li Auto delivered 36,674 new vehicles in March, a year-on-year increase of 26.5%.
ZHONG JI LS (00767.HK) and Huali Life have established a joint venture to provide longevity health services in China.
On April 1, Gelonghui reported that ZHONG JI LS (00767.HK) announced that on April 1, 2025, its wholly-owned subsidiary Shenzhen ZHONG JI LS Co., Ltd. (Chalkis Health Industry) signed a joint venture agreement with Huali (Guangdong) Life Science Technology Co., Ltd. (Huali Life) to establish a joint venture company in China, which will have 51% owned by Chalkis Health Industry and 49% owned by Huali Life at the time of establishment. The joint venture company will primarily provide longevity health services in China. The initial registered capital of the joint venture company is 1,000,000 RMB, which will be contributed by Chalkis Health Industry and Huali.
ZHONG JI LS: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024
Zhong Ji Longevity Science Forecasts Loss in 2024
According to the profit warning, ZHONG JI LS (00767.HK) expects to incur a loss of at least 32 million yuan for the entire year.
ZHONG JI LS (00767.HK) issued a profit warning, anticipating a net loss attributable to shareholders of the company in the range of 32 million to 35 million yuan for the fiscal year 2024, compared to a profit of 2.3 million yuan last year. This is mainly due to non-recurring legal and service fees of approximately 20.4 million yuan incurred from the collection of a long-term outstanding loan from a subsidiary; significant marketing costs related to the MNM supplements for the ZHONG JI LS business in mainland China; and substantial restructuring costs associated with the withdrawal of the MNM dietary supplements retail sector and other health product lines.
